Free Trial

HighPoint Advisor Group LLC Takes $215,000 Position in Allegion PLC (NYSE:ALLE)

Allegion logo with Industrials background

HighPoint Advisor Group LLC purchased a new stake in Allegion PLC (NYSE:ALLE - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 1,557 shares of the scientific and technical instruments company's stock, valued at approximately $215,000.

A number of other institutional investors and hedge funds have also bought and sold shares of ALLE. Whittier Trust Co. raised its position in Allegion by 16.6% during the first quarter. Whittier Trust Co. now owns 576 shares of the scientific and technical instruments company's stock valued at $75,000 after purchasing an additional 82 shares in the last quarter. Waterloo Capital L.P. lifted its stake in Allegion by 1.2% during the fourth quarter. Waterloo Capital L.P. now owns 7,180 shares of the scientific and technical instruments company's stock worth $938,000 after purchasing an additional 83 shares during the last quarter. Patriot Financial Group Insurance Agency LLC lifted its stake in Allegion by 2.4% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 3,593 shares of the scientific and technical instruments company's stock worth $469,000 after purchasing an additional 83 shares during the last quarter. DMC Group LLC lifted its stake in Allegion by 2.2% during the first quarter. DMC Group LLC now owns 3,953 shares of the scientific and technical instruments company's stock worth $516,000 after purchasing an additional 85 shares during the last quarter. Finally, Rovin Capital UT ADV lifted its stake in Allegion by 2.3% during the first quarter. Rovin Capital UT ADV now owns 4,215 shares of the scientific and technical instruments company's stock worth $550,000 after purchasing an additional 96 shares during the last quarter. Institutional investors and hedge funds own 92.21% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on ALLE shares. Morgan Stanley upped their target price on Allegion from $139.00 to $151.00 and gave the stock an "equal weight" rating in a research note on Friday, July 11th. JPMorgan Chase & Co. assumed coverage on shares of Allegion in a research report on Tuesday, June 24th. They issued an "overweight" rating and a $170.00 target price on the stock. Mizuho raised their target price on shares of Allegion from $145.00 to $155.00 and gave the company a "neutral" rating in a research report on Friday. Robert W. Baird raised their target price on shares of Allegion from $150.00 to $175.00 and gave the company a "neutral" rating in a research report on Friday. Finally, The Goldman Sachs Group raised their target price on shares of Allegion from $149.00 to $170.00 and gave the company a "buy" rating in a research report on Tuesday, July 8th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $164.57.

Check Out Our Latest Stock Analysis on Allegion

Allegion Trading Up 1.1%

NYSE ALLE traded up $1.80 during mid-day trading on Friday, reaching $165.47. 1,446,818 shares of the stock were exchanged, compared to its average volume of 914,092. Allegion PLC has a one year low of $116.57 and a one year high of $166.22. The stock has a 50 day simple moving average of $144.55 and a 200-day simple moving average of $135.44. The stock has a market cap of $14.24 billion, a P/E ratio of 22.98, a P/E/G ratio of 4.01 and a beta of 1.01. The company has a debt-to-equity ratio of 1.14, a current ratio of 2.30 and a quick ratio of 1.51.

Allegion (NYSE:ALLE - Get Free Report) last posted its quarterly earnings results on Thursday, July 24th. The scientific and technical instruments company reported $2.04 earnings per share for the quarter, beating the consensus estimate of $2.00 by $0.04. Allegion had a net margin of 16.15% and a return on equity of 42.62%. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $999.10 million. During the same period in the previous year, the firm posted $1.96 earnings per share. The business's revenue was up 5.8% compared to the same quarter last year. On average, analysts anticipate that Allegion PLC will post 7.77 EPS for the current year.

Allegion Profile

(Free Report)

Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door controls and systems and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors, accessories, and other.

Featured Stories

Institutional Ownership by Quarter for Allegion (NYSE:ALLE)

Should You Invest $1,000 in Allegion Right Now?

Before you consider Allegion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allegion wasn't on the list.

While Allegion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines